19-40366857-G-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_012268.4(PLD3):c.187G>A(p.Gly63Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000748 in 1,613,978 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Synonymous variant affecting the same amino acid position (i.e. G63G) has been classified as Likely benign.
Frequency
Consequence
NM_012268.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLD3 | NM_012268.4 | c.187G>A | p.Gly63Ser | missense_variant | 5/13 | ENST00000409735.9 | |
PLD3 | NM_001031696.4 | c.187G>A | p.Gly63Ser | missense_variant | 5/13 | ||
PLD3 | NM_001291311.2 | c.187G>A | p.Gly63Ser | missense_variant | 5/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLD3 | ENST00000409735.9 | c.187G>A | p.Gly63Ser | missense_variant | 5/13 | 1 | NM_012268.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000868 AC: 132AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000999 AC: 251AN: 251132Hom.: 3 AF XY: 0.00106 AC XY: 144AN XY: 135728
GnomAD4 exome AF: 0.000737 AC: 1077AN: 1461748Hom.: 5 Cov.: 31 AF XY: 0.000785 AC XY: 571AN XY: 727178
GnomAD4 genome AF: 0.000861 AC: 131AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.000900 AC XY: 67AN XY: 74416
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | PLD3: BP4, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 02, 2023 | - - |
PLD3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 19, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at